4.39 USD
↘ 0.08 (1.68%)AT CLOSE (11:59 AM EDT)
Aquestive Therapeutics, Inc. Common Stock
AQSTNASDAQ • USD
4.38
↘ 0.01 (0.32%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
4.38
↘ 0.01 (0.32%)
Market: CLOSED
Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $4.39. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (202.4%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$4.46
High?$4.48
Low?$4.22
Prev. Close?$4.47
Volume?7.4M
Avg. Volume?2.2M
VWAP?$4.35
Rel. Volume?3.40x
Bid / Ask
Bid?$4.36 × 500
Ask?$4.40 × 200
Spread?$0.04
Midpoint?$4.38
Valuation & Ratios
Market Cap?550.7M
Shares Out?125.5M
Float?100.0M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?-16.17
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
560.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?83
Short Sent.?54
Piotroski F-Score?4/9Mixed
Altman Z-Score?-2.81Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?14.80%High
Short Interest?14.8M
Days to Cover?9.6
Free Float100.0M
Avg Daily Volume1.6M
Settlement Date2026-06-15
Financial Health
Current Ratio?4.10Strong
Quick Ratio?3.85Strong
Cash Ratio?3.49Strong
Debt/Equity?-1.14Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-16.17CHEAP▾
S&P97
P/S?10.96HIGH▾
Peers100
S&P7
P/FCF?N/A▾
EV/EBITDA?-8.2CHEAP▾
S&P97
EV/Sales?9.52HIGH▾
Peers100
S&P12
Returns & Efficiency
ROE?202.4%STRONG▾
Peers50
S&P97
ROA?-48.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-44317000
Enterprise Value?$478.8M
Fundamentals ratios updated end of day